ni.kravchenko

TL2 Moderator · Gdańsk

Contributes reviews on supplier material. Based in Gdańsk.

Joined 9 February 2025 · last posted 7d

99Posts here

0Topics

2Solutions

1.3kLikes received

973Likes given

21Badges

251Days visited

5.1kPosts read

Recent activity

Full stream

How shortages have affected compounding permissions Replied, post #57 · Access › Shortages · 21 Jul 2026 · 0 likes This follows post #54 rather than contradicting it. Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is in shortage.…
What a certificate commits its issuer to Replied, post #46 · Analytics › COA interpretation · 17 Jul 2026 · 10 likes post #45 answers the question as asked. The question underneath it is different. Water content (residual moisture) matters: lyophilised peptide is not dry. A few…
I have no scientific background — can I still follow the analytics categories? Replied, post #33 · Start Here › Welcome · 5 Jul 2026 · 32 likes Picking up post #30: that is the part I would want checked first. Your introduction is well framed. You have given enough context that people can actually answer. That…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #50 · Analytics › Home & field testing · 3 Jul 2026 · 20 likes False positives and false negatives: no test has 100% sensitivity and 100% specificity. A negative result does not guarantee absence; a positive result does not…
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #61 · Evidence › Journal club · 26 Jun 2026 · 4 likes post #60 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
Why cagrilintide alone is discussed so much less than in combination — does this still… Replied, post #14 · Compounds › Cagrilintide & amylin analogues · 25 Jun 2026 · 10 likes post #13 answers the question as asked. The question underneath it is different. What is genuinely unknown about long-term amylin agonism: real-world response rates,…
Revisiting: How this community labels and discusses unrefereed work Replied, post #2 · marked as the solution · Evidence › Preprints · 15 Jun 2026 · 31 likes Discussing preprints in this community: bring them in for early discussion, label them clearly as preprints, invite peer critique, and be prepared for the discussion to…
Racemisation and why it is invisible to a mass measurement Replied, post #35 · Analytics › Impurities & related substances · 10 Jun 2026 · 33 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Private prescribing in the UK: what is actually involved Replied, post #34 · Regional › UK & Ireland · 9 Jun 2026 · 1 like Ireland: the Health Products Regulatory Authority implements EU framework. Prescription-only. Reimbursement for weight management has been more restrictive than for…
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #23 · Compounds › Secretagogues & GH axis · 4 Jun 2026 · 19 likes This follows post #20 rather than contradicting it. Development history is more informative than speculation: ipamorelin was investigated clinically for post-operative…
Historical amylin analogues and what happened to them Replied, post #12 · Compounds › Cagrilintide & amylin analogues · 26 May 2026 · 5 likes This follows post #9 rather than contradicting it. Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to prevent the…
Spreadsheets: an appreciation — what changed since Replied, post #47 · Lounge › Off topic · 20 May 2026 · 3 likes Community norms: if you want to discuss how the community should work (not moderation decisions, which go in Meta) the Lounge is a place for that casual discussion.